SCHEMBL19633455

SCHEMBL19633455

CC(C)(C)OC(=O)N1CCC2(CC1)CN(c1ccc(N)c([N+](=O)[O-])c1)C2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
MAPT P10636 3/20 0.54
LMNA P02545 1/20 0.54
HDAC2 Q92769 2/20 0.48
HDAC1 Q13547 1/20 0.48
HSD17B10 Q99714 4/20 0.43
CYP3A4 P08684 3/20 0.43
USP2 O75604 3/20 0.43
CYP2C19 P33261 3/20 0.43
MAPK1 P28482 2/20 0.43
HPGD P15428 2/20 0.43
HIF1A Q16665 1/20 0.43
CYP1A2 P05177 4/20 0.43
MEN1 O00255 1/20 0.41
CYP2C9 P11712 1/20 0.41
KMT2A Q03164 1/20 0.41
MET P08581 1/20 0.40
GPR119 Q8TDV5 2/20 0.40
TSHR P16473 2/20 0.40
SCD5 Q86SK9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19633247 0.95 MAPT (0.53) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL16270621 0.87 MAPT (0.70) ALDH1A1MAPTLMNACYP2C19CYP1A2
SCHEMBL24794212 0.87 MAPT (0.52) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL30082676 0.87 MAPT (0.52) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL12006692 0.85 ALDH1A1 (0.74) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL28945679 0.85 ALDH1A1 (0.54) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL20836823 0.84 ALDH1A1 (0.47) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL30745784 0.84 ALDH1A1 (0.47) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL24793976 0.84 HDAC2 (0.52) ALDH1A1MAPTLMNAHDAC2HDAC1
SCHEMBL29709632 0.84 HDAC2 (0.52) ALDH1A1MAPTLMNAHDAC2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12358898-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2025-07-15 US disclosed
US-20240018130-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2024-01-18 US disclosed
US-20240018130-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2024-01-18 US disclosed
US-11827625-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. 2023-11-28 US disclosed
US-11827625-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. 2023-11-28 US disclosed
US-20210221797-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2021-07-22 US disclosed
US-11001572-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. 2021-05-11 US disclosed
US-20200207745-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2020-07-02 US disclosed
US-10654836-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2020-05-19 US disclosed
US-20190161476-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2019-05-30 US disclosed
EP-3459952-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME AND USE THEREOF IN MEDICINE Zhejiang Hisun Pharmaceutical Co., Ltd. (CN) 2019-03-27 EP disclosed
WO-2017198221-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME AND USE THEREOF IN MEDICINE 浙江海正药业股份有限公司 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207745-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885
US-11827625-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885
US-12358898-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885
US-10654836-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885
US-20240018130-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885
US-20190161476-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885
US-20210221797-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885
US-11001572-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine FGFR4, FGFR1, FGFR2 ALDH1A1 1084/4885MAPT 2403/4885LMNA 4760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.